Lying Positions in Intramuscular Injection

The Effect of Three Different Lying Positions on Pain, Comfort, and Satisfaction Levels in Intramuscular Injection: A Randomized Controlled Trial

Status

Not yet recruiting

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT07586605

Acronym

Lying

Enrollment

111

Registered

2026-05-14

Start date

2026-04-30

Completion date

2026-08-30

Last updated

2026-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ventrogluteal Injections

Keywords

intramuscular injection, lying position, pain, patient satisfaction

Brief summary

The aim of this study is to examine the effects of intramuscular (IM) injections administered in three different lying positions (supine, prone, and lateral) into the ventrogluteal site on patient pain, comfort, and procedural satisfaction. The study will be conducted as a randomized controlled experimental trial with three groups. In Experimental Group 1, patients will be placed in the supine position; in Experimental Group 2, the lateral position; and in Experimental Group 3, the prone position prior to the injection procedure, followed by an IM injection into the ventrogluteal site. Subsequent to the procedure, patients' pain, comfort, and procedural satisfaction levels will be assessed.

Interventions

PROCEDURELying before procedure

Lying position before intramuscular injection

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SCREENING

Masking

SINGLE (Outcomes Assessor)

Intervention model description

Randomized controlled study

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Being 18 years of age or older, * Having received an IM injection at least one week prior to the study, * Absence of scars, ecchymosis, or hematomas at the injection site, * Having a BMI between 18.5 and 24.9 kg/m², * Absence of lower extremity paralysis, * Not receiving any oral or parenteral analgesic treatment prior to the injection.

Exclusion criteria

* Failure of the patient to respond to the questions in the post-procedure data collection form.

Design outcomes

Primary

Measure	Time frame	Description
Visual Analog Scale (VAS) Score for Pain	during the procedure	patient's pain level (0-10)

Secondary

Measure	Time frame	Description
Procedural Satisfaction Score	during the procedure	The Visual Analog Scale (VAS) (0-10) will be employed to measure the degree of patient satisfaction.
Patient Comfort Level	During the procedure	The Visual Analog Scale (VAS) (0-10) will be employed to measure the degree of patient comfort level

Countries

Turkey (Türkiye)

Contacts

CONTACTHandan Eren, PhD

erennhandan@gmail.com+905438712771

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 23, 2026